Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 664,229	$ (1,970)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Stock-based compensation expense to certain officers and directors	207,087
Interest earned on marketable securities held in Trust Account	(1,632,278)
Unrealized loss on marketable securities held in Trust Account	21,578
Deferred benefit from income taxes	(4,123)
Changes in operating assets and liabilities:
Prepaid expenses	(143,822)	21,667
Prepaid insurance	(52,556)
Accounts payable and accrued expenses	221,709	(677)
Income taxes payable	310,848
Net cash (used in) provided by operating activities	(407,328)	19,020
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(70,380,000)
Net cash used in investing activities	(70,380,000)
Cash Flows from Financing Activities:
Proceeds from sale of units, net of underwriting discounts paid	67,965,000
Proceeds from sale of private placement units	3,945,000
Advances from related party		100,000
Proceeds from promissory note - related party	100,085	100,000
Payment of offering costs	(581,635)	(209,627)
Net cash provided by (used in) financing activities	71,428,450	(9,627)
Net Change in Cash	641,122	9,393
Cash – Beginning of period	34,393	25,000
Cash – End of period	675,515	34,393
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs	75,000	23,552
Issuance of founder shares through reclassification of advance from related party		25,000
Accretion of Class A common stock to redemption value	7,061,204
Deferred underwriting fee payable	$ 2,070,000